missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Terazosin Hydrochloride Pharmaceutical Secondary Standard, MilliporeSigma™ Supelco™
Supplier: Merck Emd Millipore PHR17211G
Description
Terazosin Hydrochloride belongs to the class of a1-adrenergic blockers, widely used for the treatment of benign prostatic hyperplasia (BPH) affecting the urogenital tract in men.Certified pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards.Specifications
| 70024-40-7 | |
| C19H25N5O4 · HCl · 2H2 O | |
| Terazosin hydrochloride dihydrate; 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)carbonyl]piperazine hydrochloride dihydrate | |
| 1 g | |
| Certified Reference Material |
| These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available. | |
| MFCD00941408 | |
| Certified Reference Material | |
| 459.92 |